Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
docetaxel (taxotere) (2 trials)
edoxaban (savaysa) (1 trial)
eribulin (halaven) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (2 trials)
pertuzumab (perjeta) (1 trial)
trastuzumab (herceptin) (1 trial)
vinorelbine (navelbine) (1 trial)
bevacizumab (avastin) (1 trial)
capecitabine (xeloda) (1 trial)
cediranib (1 trial)
fluorouracil (efudex) (2 trials)
irinotecan (Camptosar) (1 trial)
leucovorin (2 trials)
oxaliplatin (eloxatin) (2 trials)
Atrial Fibrillation (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Colorectal Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Renal Insufficiency (Phase 3)
Trials (5 total)
Trial APIs (16 total)